116 related articles for article (PubMed ID: 25239114)
1. Tutorial on health economics and outcomes research in nutrition.
Philipson T; Linthicum MT; Snider JT
JPEN J Parenter Enteral Nutr; 2014 Nov; 38(2 Suppl):5S-16S. PubMed ID: 25239114
[TBL] [Abstract][Full Text] [Related]
2. Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States.
Frueh FW
Value Health; 2013; 16(6 Suppl):S27-31. PubMed ID: 24034309
[TBL] [Abstract][Full Text] [Related]
3. Understanding cost-effectiveness.
Zilberberg MD; Shorr AF
Clin Microbiol Infect; 2010 Dec; 16(12):1707-12. PubMed ID: 20673258
[TBL] [Abstract][Full Text] [Related]
4. A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topics.
Neumann PJ; Saret CJ
Expert Rev Pharmacoecon Outcomes Res; 2013 Oct; 13(5):657-61. PubMed ID: 24138650
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic outcomes of nutrition interventions across the continuum of care.
de van der Schueren M; Elia M; Gramlich L; Johnson MP; Lim SL; Philipson T; Jaferi A; Prado CM
Ann N Y Acad Sci; 2014 Aug; 1321():20-40. PubMed ID: 25123208
[TBL] [Abstract][Full Text] [Related]
6. Preliminary evidence for a medical nutrition therapy protocol: enteral feedings for critically ill patients.
Kattelmann KK; Hise M; Russell M; Charney P; Stokes M; Compher C
J Am Diet Assoc; 2006 Aug; 106(8):1226-41. PubMed ID: 16863719
[TBL] [Abstract][Full Text] [Related]
7. Health economic studies: an introduction to cost-benefit, cost-effectiveness, and cost-utility analyses.
Angevine PD; Berven S
Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S9-15. PubMed ID: 25299265
[TBL] [Abstract][Full Text] [Related]
8. Health economics and outcomes research within drug development: challenges and opportunities for reimbursement and market access within biopharma research.
van Nooten F; Holmstrom S; Green J; Wiklund I; Odeyemi IA; Wilcox TK
Drug Discov Today; 2012 Jun; 17(11-12):615-22. PubMed ID: 22366662
[TBL] [Abstract][Full Text] [Related]
9. Making the case for cost-effectiveness research.
Abbott DE; Sutton JM; Edwards MJ
J Surg Oncol; 2014 May; 109(6):509-15. PubMed ID: 24374952
[TBL] [Abstract][Full Text] [Related]
10. Health Economics in Medical Nutrition: An Emerging Science.
Nuijten M
Nestle Nutr Inst Workshop Ser; 2015; 82():129-41. PubMed ID: 26545115
[TBL] [Abstract][Full Text] [Related]
11. Economic outcomes and contemporary pharmacy practice.
Reeder CE
Am Pharm; 1993 Dec; NS33(12 Suppl):S3-6. PubMed ID: 8109541
[TBL] [Abstract][Full Text] [Related]
12. [9th Jesús Culebras Lecture: "The value of clinical nutrition"].
Álvarez Hernández J
Nutr Hosp; 2018 Dec; 35(6):1467-1478. PubMed ID: 30525862
[TBL] [Abstract][Full Text] [Related]
13. The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence.
Campbell JD; McQueen RB; Briggs A
Ann Am Thorac Soc; 2014 Feb; 11 Suppl 2():S105-11. PubMed ID: 24559022
[TBL] [Abstract][Full Text] [Related]
14. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
Siebert U; Rochau U; Claxton K
Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the health economic impact of medical nutrition in the Netherlands.
Freijer K; Nuijten MJ
Eur J Clin Nutr; 2010 Oct; 64(10):1229-34. PubMed ID: 20717125
[TBL] [Abstract][Full Text] [Related]
16. Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging Markets.
Holtorf AP; Brixner D; Bellows B; Keskinaslan A; Dye J; Oderda G
Am Health Drug Benefits; 2012 Nov; 5(7):428-38. PubMed ID: 24991339
[TBL] [Abstract][Full Text] [Related]
17. Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value.
Chen Y; Guzauskas GF; Gu C; Wang BC; Furnback WE; Xie G; Dong P; Garrison LP
J Pers Med; 2016 Nov; 6(4):. PubMed ID: 27827859
[TBL] [Abstract][Full Text] [Related]
18. Preventing pressure ulcers in long-term care: a cost-effectiveness analysis.
Pham B; Stern A; Chen W; Sander B; John-Baptiste A; Thein HH; Gomes T; Wodchis WP; Bayoumi A; Machado M; Carcone S; Krahn M
Arch Intern Med; 2011 Nov; 171(20):1839-47. PubMed ID: 21949031
[TBL] [Abstract][Full Text] [Related]
19. Health Economics and Outcomes Research of Wound Care: Overview of Methodology.
Gilligan AM
Adv Wound Care (New Rochelle); 2018 Nov; 7(11):380-386. PubMed ID: 30479871
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of hospice care.
Robinson BE; Pham H
Clin Geriatr Med; 1996 May; 12(2):417-28. PubMed ID: 8799358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
